Olanzapine in Patients With Borderline Personality Disorder

NCT00091650 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Borderline Personality Disorder

Interventions

DRUG: Olanzapine
DRUG: placebo

Sponsor

Eli Lilly and Company